Oncolytics Biotech Inc.
NASDAQ: ONCY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jared Kelly
- Employees
- 29
- Headquarters
- Calgary, Canada
- IPO year
- 2001
- Market cap
- $92.5M
- Website
- http://www.oncolyticsbiotech.com
Loading ONCY…
Loading profile data…Frequently asked questions about ONCY
What does Oncolytics Biotech Inc. (ONCY) do?
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metasta...
Where does ONCY trade?
Oncolytics Biotech Inc. (ONCY) trades on the NASDAQ.
What sector is ONCY in?
Oncolytics Biotech Inc. (ONCY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oncolytics Biotech Inc.?
Jared Kelly is the chief executive officer of Oncolytics Biotech Inc. (ONCY).
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Canada.
Does ONCY pay a dividend?
Oncolytics Biotech Inc. (ONCY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ONCY go public?
Oncolytics Biotech Inc. (ONCY) completed its initial public offering in 2001.